Lista de obras - Elgene Lim - Dominio Público Uruguay

A laminin 511 matrix is regulated by TAZ and functions as the ligand for the α6Bβ1 integrin to sustain breast cancer stem cells.

artículo científico publicado en 2015

A new sophistication for breast cancer PDXs

artículo científico publicado en 2022

A quantitative mass spectrometry-based approach to monitor the dynamics of endogenous chromatin-associated protein complexes.

artículo científico publicado en 2018

A single-cell and spatially resolved atlas of human breast cancers

artículo científico publicado en 2021

Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers

artículo científico publicado en 2009

Adjuvant chemotherapy in luminal breast cancers.

artículo científico

Adjuvant endocrine therapy in women with oestrogen-receptor-positive breast cancer: how should the skeletal and vascular side effects be assessed and managed?

artículo científico publicado en 2016

Assessment and management of bone health in women with oestrogen receptor-positive breast cancer receiving endocrine therapy: Position statement of the Endocrine Society of Australia, the Australian and New Zealand Bone & Mineral Society, the Austral

article

Attitudes of patients with metastatic cancer towards research biopsies

artículo científico publicado en 2017

Breast cancer in adolescents and young adults: a review with a focus on biology

artículo científico publicado en 2013

CDK12 Inhibition Reverses De Novo and Acquired PARP Inhibitor Resistance in BRCA Wild-Type and Mutated Models of Triple-Negative Breast Cancer

artículo científico publicado en 2016

CDK7-dependent transcriptional addiction in triple-negative breast cancer.

artículo científico publicado en 2015

Clinical Overview of MDM2/X-Targeted Therapies

artículo científico publicado en 2016

Computational Screening of Anti-Cancer Drugs Identifies a New BRCA Independent Gene Expression Signature to Predict Breast Cancer Sensitivity to Cisplatin

scientific article published on 13 May 2022

Corrigendum: IRAK1 is a therapeutic target that drives breast cancer metastasis and resistance to paclitaxel

artículo científico publicado en 2015

Desmoplastic melanoma: comparison of expression of differentiation antigens and cancer testis antigens

scientific article published on 01 August 2006

EMT, cell plasticity and metastasis

artículo científico publicado en 2016

Emerging data and future directions for CDK4/6 inhibitor treatment of patients with hormone receptor positive HER2-non-amplified metastatic breast cancer

scientific article published on 01 October 2018

Enhancer-Mediated Oncogenic Function of the Menin Tumor Suppressor in Breast Cancer.

artículo científico publicado en 2017

Evaluation of FGFR targeting in breast cancer through interrogation of patient-derived models

artículo científico publicado en 2021

Hormone receptor positive, HER2 negative metastatic breast cancer: Impact of CDK4/6 inhibitors on the current treatment paradigm

artículo científico publicado en 2018

IMP3 promotes stem-like properties in triple-negative breast cancer by regulating SLUG.

artículo científico publicado en 2015

IRAK1 is a therapeutic target that drives breast cancer metastasis and resistance to paclitaxel.

artículo científico publicado en 2015

Importance of Breast Cancer Subtype in the Development of Androgen Receptor Directed Therapy

artículo científico publicado en 2014

IκB kinase ε phosphorylates TRAF2 to promote mammary epithelial cell transformation

artículo científico publicado en 2012

MECP2 Is a Frequently Amplified Oncogene with a Novel Epigenetic Mechanism That Mimics the Role of Activated RAS in Malignancy

artículo científico publicado en 2015

MELK is an oncogenic kinase essential for mitotic progression in basal-like breast cancer cells.

artículo científico publicado en 2014

Microenvironmental control of breast cancer subtype elicited through paracrine platelet-derived growth factor-CC signaling.

artículo científico publicado en 2018

Neoadjuvant Interferons: Critical for effective PD-1 based immunotherapy in TNBC.

artículo científico

Non-canonical AR activity facilitates endocrine resistance in breast cancer

scientific article published on 01 February 2019

Optimizing the approach to patients with potentially resectable liver metastases from colorectal cancer.

artículo científico publicado en 2007

Overcoming CDK4/6 inhibitor resistance in ER positive breast cancer

artículo científico publicado en 2019

PARP1-driven poly-ADP-ribosylation regulates BRCA1 function in homologous recombination-mediated DNA repair.

artículo científico publicado en 2014

PDEF promotes luminal differentiation and acts as a survival factor for ER-positive breast cancer cells

artículo científico publicado en 2013

Phosphorylation of ETS1 by Src family kinases prevents its recognition by the COP1 tumor suppressor

artículo científico publicado en 2014

Protein kinase C α is a central signaling node and therapeutic target for breast cancer stem cells

artículo científico publicado en 2013

Pushing estrogen receptor around in breast cancer

artículo científico publicado en 2016

Renewed interest in the progesterone receptor in breast cancer

artículo científico publicado en 2016

Secreted tumor antigens - immune biomarkers for diagnosis and therapy.

artículo científico publicado en 2017

Sensitization of BCL-2-expressing breast tumors to chemotherapy by the BH3 mimetic ABT-737

artículo científico publicado en 2011

Sensitizing HR-proficient cancers to PARP inhibitors

artículo científico publicado en 2017

Targeting androgen receptor in estrogen receptor-negative breast cancer

artículo científico publicado en 2011

Targeting stromal remodeling and cancer stem cell plasticity overcomes chemoresistance in triple negative breast cancer

artículo científico publicado en 2018

Targeting the androgen receptor in breast cancer

artículo científico

The RasGAP gene, RASAL2, is a tumor and metastasis suppressor

artículo científico publicado en 2013

The impact of ethnicity on efficacy and toxicity of cyclin D kinase 4/6 inhibitors in advanced breast cancer: a meta-analysis

article

The influence of language spoken on colorectal cancer diagnosis and management

artículo científico publicado en 2006

The innate and adaptive infiltrating immune systems as targets for breast cancer immunotherapy

artículo científico publicado en 2017

The innate and adaptive infiltrating immune systems as targets for breast cancer immunotherapy.

artículo científico publicado en 2017

The role of MDM2 and MDM4 in breast cancer development and prevention.

artículo científico publicado en 2017

Transcriptome analyses of mouse and human mammary cell subpopulations reveal multiple conserved genes and pathways

artículo científico publicado en 2010

Vinorelbine Potently Induces Placental Cell Death, Does Not Harm Fertility and is a Potential Treatment for Ectopic Pregnancy.

artículo científico publicado en 2018

XBP1 promotes triple-negative breast cancer by controlling the HIF1α pathway

artículo científico publicado en 2014

Lista de obras de Elgene Lim

A laminin 511 matrix is regulated by TAZ and functions as the ligand for the α6Bβ1 integrin to sustain breast cancer stem cells.

A new sophistication for breast cancer PDXs

A quantitative mass spectrometry-based approach to monitor the dynamics of endogenous chromatin-associated protein complexes.

A single-cell and spatially resolved atlas of human breast cancers

Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers

Adjuvant chemotherapy in luminal breast cancers.

Adjuvant endocrine therapy in women with oestrogen-receptor-positive breast cancer: how should the skeletal and vascular side effects be assessed and managed?

Assessment and management of bone health in women with oestrogen receptor-positive breast cancer receiving endocrine therapy: Position statement of the Endocrine Society of Australia, the Australian and New Zealand Bone & Mineral Society, the Austral

Attitudes of patients with metastatic cancer towards research biopsies

Breast cancer in adolescents and young adults: a review with a focus on biology

CDK12 Inhibition Reverses De Novo and Acquired PARP Inhibitor Resistance in BRCA Wild-Type and Mutated Models of Triple-Negative Breast Cancer

CDK7-dependent transcriptional addiction in triple-negative breast cancer.

Clinical Overview of MDM2/X-Targeted Therapies

Computational Screening of Anti-Cancer Drugs Identifies a New BRCA Independent Gene Expression Signature to Predict Breast Cancer Sensitivity to Cisplatin

Corrigendum: IRAK1 is a therapeutic target that drives breast cancer metastasis and resistance to paclitaxel

Desmoplastic melanoma: comparison of expression of differentiation antigens and cancer testis antigens

EMT, cell plasticity and metastasis

Emerging data and future directions for CDK4/6 inhibitor treatment of patients with hormone receptor positive HER2-non-amplified metastatic breast cancer

Enhancer-Mediated Oncogenic Function of the Menin Tumor Suppressor in Breast Cancer.

Evaluation of FGFR targeting in breast cancer through interrogation of patient-derived models

Hormone receptor positive, HER2 negative metastatic breast cancer: Impact of CDK4/6 inhibitors on the current treatment paradigm

IMP3 promotes stem-like properties in triple-negative breast cancer by regulating SLUG.

IRAK1 is a therapeutic target that drives breast cancer metastasis and resistance to paclitaxel.

Importance of Breast Cancer Subtype in the Development of Androgen Receptor Directed Therapy

IκB kinase ε phosphorylates TRAF2 to promote mammary epithelial cell transformation

MECP2 Is a Frequently Amplified Oncogene with a Novel Epigenetic Mechanism That Mimics the Role of Activated RAS in Malignancy

MELK is an oncogenic kinase essential for mitotic progression in basal-like breast cancer cells.

Microenvironmental control of breast cancer subtype elicited through paracrine platelet-derived growth factor-CC signaling.

Neoadjuvant Interferons: Critical for effective PD-1 based immunotherapy in TNBC.

Non-canonical AR activity facilitates endocrine resistance in breast cancer

Optimizing the approach to patients with potentially resectable liver metastases from colorectal cancer.

Overcoming CDK4/6 inhibitor resistance in ER positive breast cancer

PARP1-driven poly-ADP-ribosylation regulates BRCA1 function in homologous recombination-mediated DNA repair.

PDEF promotes luminal differentiation and acts as a survival factor for ER-positive breast cancer cells

Phosphorylation of ETS1 by Src family kinases prevents its recognition by the COP1 tumor suppressor

Protein kinase C α is a central signaling node and therapeutic target for breast cancer stem cells

Pushing estrogen receptor around in breast cancer

Renewed interest in the progesterone receptor in breast cancer

Secreted tumor antigens - immune biomarkers for diagnosis and therapy.

Sensitization of BCL-2-expressing breast tumors to chemotherapy by the BH3 mimetic ABT-737

Sensitizing HR-proficient cancers to PARP inhibitors

Targeting androgen receptor in estrogen receptor-negative breast cancer

Targeting stromal remodeling and cancer stem cell plasticity overcomes chemoresistance in triple negative breast cancer

Targeting the androgen receptor in breast cancer

The RasGAP gene, RASAL2, is a tumor and metastasis suppressor

The impact of ethnicity on efficacy and toxicity of cyclin D kinase 4/6 inhibitors in advanced breast cancer: a meta-analysis

The influence of language spoken on colorectal cancer diagnosis and management

The innate and adaptive infiltrating immune systems as targets for breast cancer immunotherapy

The innate and adaptive infiltrating immune systems as targets for breast cancer immunotherapy.

The role of MDM2 and MDM4 in breast cancer development and prevention.

Transcriptome analyses of mouse and human mammary cell subpopulations reveal multiple conserved genes and pathways

Vinorelbine Potently Induces Placental Cell Death, Does Not Harm Fertility and is a Potential Treatment for Ectopic Pregnancy.

XBP1 promotes triple-negative breast cancer by controlling the HIF1α pathway